USE OF 5-(2-((5-(4-(DIMETHYLAMINO)PIPERIDIN-1-YL)PYRIDIN-2-YL)AMINO)-5-FLUOROPYRIMIDIN-4-YL)-N,4-DIMETHYLTHIAZOL-2-AMINE IN COMBINATION THERAPIES FOR CANCER
Publication
EP4493192A1
Kind: A1
Mar 18, 2026
Applicants
Aucentra Therapeutics Pty Ltd
Inventors
WANG, Shudong, LENJISA, Jimma L
IPC Classifications
A61K 31/506 20060101AFI20260212BHEP
A61K 39/395 20060101ALI20260212BHEP
A61P 35/00 20060101ALI20260212BHEP
C07K 16/28 20060101ALI20260212BHEP
A61K 45/06 20060101ALI20260212BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR